, Volume 22, Issue 2, pp 151–161 | Cite as

The role of brain norepinephrine in the anorexic effects of dextroamphetamine and monoamine oxidase inhibitors in the rat

  • Stephen G. Holtzman
  • Robert E. Jewett
Animal Studies


The effects of d-amphetamine on food and water intake and brain monoamine concentrations in rats that had been deprived of food and water for 24 h were compared with those of two MAO inhibitors: tranylcypromine which has prominent amphetamine-like activity; and, pargyline which does not. All drugs produced dose-related depressions of food and water intake. The anorexic effects of the MAO inhibitors were correlated, over a 16-fold dose range, with elevated levels of norepinephrine, dopamine and serotonin. The anorexic effect of d-amphetamine was blocked by α-methyltyrosine, an inhibitor of catecholamine synthesis. α-Methyltyrosine failed to block the depression of food and water intake caused by the MAO inhibitors, although the rise in catecholamine levels was prevented. It was concluded that the mechanisms by which d-amphetamine produces anorexia may differ from those of the MAO inhibitors. Central adrenergic mediation appears to play a role in the anorexic activity of d-amphetamine, but may not be essential for the anorexic effect of tranylcypromine and pargyline.


Anorexia Amphetamine Monoamine Oxidase Inhibitor Norepinephrine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ansell, G. B., Beeson, M. F.: A rapid and sensitive procedure for the combined assay of noradrenaline, dopamine, and serotonin in a single brain sample. Analyt. Biochem. 23, 196–206 (1968).Google Scholar
  2. Anton, A. H., Sayre, D. F.: A study of the factors affecting the aluminum oxidetrihydroxyindole procedure for the analysis of catecholamines. J. Pharmacol. exp. Ther. 138, 360–375 (1962).Google Scholar
  3. Borella, L. E., Paquette, R., Herr, F.: The effect of some CNS depressants on the hypermotility and anorexia induced by amphetamine in rats. Canad. J.Physiol. 47, 841–847 (1969).Google Scholar
  4. Carlsson, A., Fuxe, B., Hamberger, B., Lindqvist, M.: Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons. Acta physiol. scand. 67, 481–497 (1966).Google Scholar
  5. —, Lindqvist, M., Magnusson, T.: The effect of monoamine oxidase inhibitors on the metabolism of the brain catecholamines. J. Soc. Ciěnc. méd. Lisboa 123 (Suppl.), 96–98 (1959).Google Scholar
  6. — — —: On the biochemistry and possible functions of dopamine and noradrenaline in brain. In: Adrenergic mechanisms, pp. 432–439. J. R. Vane, G. E. W. Wolstenholme and M. O'Conner, eds. London: J. & A. Churchill 1960.Google Scholar
  7. Costa, E., Gropetti, A.: Biosynthesis and storage of catecholamines in tissues of rats injected with various doses of d-amphetamine. In: Amphetamines and related compounds, pp. 231–255. E. Costa and S. Garattini, eds. New York: Raven Press 1970.Google Scholar
  8. Dunnett, C. W.: A multiple comparison procedure for comparing several treatments with a control. J. Amer. Stat. Ass. 50, 1096–1121 (1955).Google Scholar
  9. Mantegazza, P., Müller, E. E., Naimzada, N. K., Riva, M.: Studies on the lack of correlation between hyperthermia, hyperactivity and anorexia induced by amphetamine. In: Amphetamines and related compounds, pp. 559–575. E. Costa and S. Garattini, eds. New York: Raven Press 1970.Google Scholar
  10. Modell, W.: Status and prospect of drugs for overeating. J. Amer. med. Ass. 173, 1131–1136 (1960).Google Scholar
  11. Moore, K. E., Lariviere, E. W.: Effects of d-amphetamine and restraint on the content of norepinephrine and dopamine in rat brain. Biochem. Pharmacol. 12, 1283–1288 (1963).Google Scholar
  12. Myers, R. D., Yaksh, T. L.: Feeding and temperature responses in the unrestrained rat after injections of cholinergic and aminergic substances into the cerebral ventricles. Physiol. Behav. 3, 917–928 (1968).Google Scholar
  13. Nathanson, M. H.: The central action of beta-aminopropylbenzene (Benzedrine). J. Amer. med. Ass. 108, 528–531 (1937).Google Scholar
  14. Pletscher, A.: Monoamine oxidase inhibitors. Pharmacol. Rev. 18, 121–129 (1966).Google Scholar
  15. Randrup, A., Munkvad, I., Udsen, P.: Adrenergic mechanisms and amphetamine induced abnormal behavior. Acta pharmacol. (Kbh.) 20, 145–157 (1963).Google Scholar
  16. Rech, R. H., Stolk, J. M.: Amphetamine-drug interactions that relate brain catecholamines to behavior. In: Amphetamines and related compounds, pp. 385–413, E. Costa and S. Garattini, eds. New York: Raven Press 1970.Google Scholar
  17. Soulairac, A.: The adrenergic and cholinergic control of food and water intake. Ann. N. Y. Acad. Sci. 157, 934–961 (1969).Google Scholar
  18. —, Soulairac, M. L.: Action de la réserpine de la sérotonine et de l'ipronizide sur le comportement alimentaire du rat. C. R. Soc. Biol. (Paris) 154, 510–513 (1960).Google Scholar
  19. Spector, S.: Monoamine oxidase in control of brain serotonin and norepinephrine content. Ann. N. Y. Acad. Sci. 107, 856–861 (1963).Google Scholar
  20. —, Sjoerdsma, A., Udenfriend, S.: Blockade of endogenous norepinephrine synthesis by α-methyl-tyrosine, an inhibitor of tyrosine hydroaxylase. J. Pharmacol. exp. Ther. 147, 86–95 (1965).Google Scholar
  21. Stein, L.: Self-stimulation of the brain and the central stimulant action of amphetamine. Fed. Proc. 23, 836–850 (1964).Google Scholar
  22. Tainter, M. L.: Actions of benzedrine and propadrine in the control of obesity. J. Nutr. 27, 89–105 (1944).Google Scholar
  23. Ulrich, H.: Narcolepsy and its treatment with benzedrine sulfate. New Engl. J. Med. 217, 696–701 (1937).Google Scholar
  24. Weiss, B., Laties, V. G.: Behavioral pharmacology and toxicology. Ann. Rev. Pharmacol. 9, 297–326 (1969).Google Scholar
  25. Weissman, A., Koe, B. K., Tenen, S. S.: Antiamphetamine effects following inhibition of tyrosine hydroxylase. J. Pharmacol. exp. Ther. 151, 339–352 (1966).Google Scholar

Copyright information

© Springer-Verlag 1971

Authors and Affiliations

  • Stephen G. Holtzman
    • 1
  • Robert E. Jewett
    • 1
  1. 1.Department of PharmacologyEmory UniversityAtlanta

Personalised recommendations